Phizzle
Data Integrity for the Pharmaceutical Industry
Overview
Raised: $141,858
Rolling Commitments ($USD)
03/30/2023
$1,202
176
2005
Healthcare & Pharmaceuticals
HealthTech
B2B
Low
Low
Summary Profit and Loss Statement
Most Recent Year | Prior Year | |
---|---|---|
Revenue |
$869,326 |
$1,365,296 |
COGS |
$507,569 |
$334,648 |
Tax |
$0 |
$0 |
| ||
| ||
Net Income |
$-2,454,298 |
$-1,765,819 |
Summary Balance Sheet
Most Recent Year | Prior Year | |
---|---|---|
Cash |
$615,364 |
$722,081 |
Accounts Receivable |
$24,218 |
$308,561 |
Total Assets |
$724,602 |
$1,113,142 |
Short-Term Debt |
$3,567,707 |
$789,019 |
Long-Term Debt |
$141,228 |
$954,036 |
Total Liabilities |
$3,708,935 |
$1,743,055 |
Upgrade to gain access
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual